United States · FDA National Drug Code directory
Memantine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-852_4ece2bda-d26f-494f-93df-bc53c494caf9
- Product NDC
- 16571-852
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- memantine
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250601
- Source listing expiry
- 20261231
Source-listed ingredients
- MEMANTINE HYDROCHLORIDE — 7 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-852-03) · 16571-852-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →